Vascular endothelial growth factor (VEGF) in neuroendocrine (NE) cells: A marker of prostate cancer (PCA) progression modulated by hormone ablation

被引：0
|
作者：
Andonian, S
Dam, V
Begin, L
Chevalier, S
Aprikian, A
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting
    Borre, M
    Nerstrom, B
    Overgaard, J
    CLINICAL CANCER RESEARCH, 2000, 6 (05) : 1882 - 1890
  • [32] The Influence of Vascular Endothelial Growth Factor (VEGF) Polymorphism on the Progression of Chronic Glomerulonephritides
    Safrankova, H.
    Merta, M.
    Reiterova, J.
    Stekrova, J.
    Maixnerova, D.
    Rysava, R.
    Skibova, J.
    Tesar, V.
    FOLIA BIOLOGICA, 2011, 57 (04) : 145 - 150
  • [33] The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression
    Recchia, Francesco
    Candeloro, Giampiero
    Desideri, Giovambattista
    Necozione, Stefano
    Rea, Silvio
    CANCER RESEARCH, 2011, 71
  • [34] Urinary levels of vascular endothelial growth factor in patients with prostate cancer as a predictor of disease progression
    Miyake, H
    Muramaki, M
    Kurahashi, T
    Yamanaka, K
    Hara, I
    ANTICANCER RESEARCH, 2005, 25 (05) : 3645 - 3649
  • [35] Vascular endothelial growth factor (VEGF) and VEGF receptor 1 in malignant and nonmalignant prostate tissue
    Koellermann, JW
    Helpap, B
    JOURNAL OF UROLOGY, 2002, 167 (04): : 137 - 137
  • [36] Vascular endothelial growth factor is a marker of metastatic breast cancer
    Li, JL
    Blann, AD
    Kumar, S
    Kumar, P
    Bundred, NJ
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3019 - P3019
  • [37] Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells
    Collado, B
    Gutiérrez-Cañas, I
    Rodríguez-Henche, N
    Prieto, JC
    Carmena, MJ
    REGULATORY PEPTIDES, 2004, 119 (1-2) : 69 - 75
  • [38] Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer
    Jones, A
    Fujiyama, C
    Turner, K
    Fuggle, S
    Cranston, D
    Bicknell, R
    Harris, AL
    BJU INTERNATIONAL, 2000, 85 (03) : 276 - 280
  • [39] Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF)
    Ling, MT
    Lau, TCM
    Zhou, C
    Chua, CW
    Kwok, WK
    Wang, Q
    Wang, XH
    Wong, YC
    CARCINOGENESIS, 2005, 26 (10) : 1668 - 1676
  • [40] Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome
    Green, Melanie M. L.
    Hiley, Crispin T.
    Shanks, Jonathan H.
    Bottomley, Ian C.
    Hons, B. A.
    West, Catharine M. L.
    Cowan, Richard A.
    Stratford, Ian J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 84 - 90
12345